| Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia N Toft, H Birgens, J Abrahamsson, L Griškevičius, H Hallböök, M Heyman, ... Leukemia 32 (3), 606-615, 2018 | 360 | 2018 |
| Clinical outcome of children with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia treated between 1995 and 2005 M Aricò, M Schrappe, SP Hunger, WL Carroll, V Conter, S Galimberti, ... Journal of clinical oncology 28 (31), 4755, 2010 | 289 | 2010 |
| Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years L Hovi, UM Saarinen-Pihkala, K Vettenranta, H Saxen Bone marrow transplantation 26 (9), 999-1004, 2000 | 215 | 2000 |
| Age-and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries LL Hjalgrim, K Rostgaard, K Schmiegelow, S Söderhäll, ... Journal of the national cancer institute 95 (20), 1539-1544, 2003 | 213 | 2003 |
| Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study C Peters, JH Dalle, F Locatelli, U Poetschger, P Sedlacek, J Buechner, ... Journal of Clinical Oncology 39 (4), 295-307, 2021 | 206 | 2021 |
| Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 … K Schmiegelow, I Al-Modhwahi, MK Andersen, M Behrendtz, E Forestier, ... Blood, The Journal of the American Society of Hematology 113 (24), 6077-6084, 2009 | 162 | 2009 |
| Risk group assignment differs for children and adults 1–45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL‐2008 protocol N Toft, H Birgens, J Abrahamsson, P Bernell, L Griškevičius, H Hallböök, ... European journal of haematology 90 (5), 404-412, 2013 | 152 | 2013 |
| Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer K Ylänen, T Poutanen, P Savikurki-Heikkilä, I Rinta-Kiikka, A Eerola, ... Journal of the American College of Cardiology 61 (14), 1539-1547, 2013 | 147 | 2013 |
| Abnormal expression of apoptosis‐related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma B Nagy, T Lundán, ML Larramendy, Y Aalto, Y Zhu, T Niini, H Edgren, ... British journal of haematology 120 (3), 434-441, 2003 | 144 | 2003 |
| Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study K Schmiegelow, E Forestier, J Kristinsson, S Söderhäll, K Vettenranta, ... Leukemia 23 (3), 557-564, 2009 | 142 | 2009 |
| Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases RM Linka, SL Risse, K Bienemann, M Werner, Y Linka, F Krux, C Synaeve, ... Leukemia 26 (5), 963-971, 2012 | 137 | 2012 |
| AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemia T Niini, J Kanerva, K Vettenranta, UM Saarinen-Pihkala, S Knuutila Haematologica 85 (4), 362-366, 2000 | 130 | 2000 |
| Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia M Kontro, H Kuusanmäki, S Eldfors, T Burmeister, EI Andersson, ... Leukemia 28 (8), 1738-1742, 2014 | 126 | 2014 |
| Acute lymphoblastic leukemia in adolescents and young adults in Finland A Usvasalo, R Räty, S Knuutila, K Vettenranta, A Harila-Saari, E Jantunen, ... Haematologica 93 (8), 1161-1168, 2008 | 123 | 2008 |
| Molecular and clinical heterogeneity in CLCN7‐dependent osteopetrosis: report of 20 novel mutations A Pangrazio, M Pusch, E Caldana, A Frattini, E Lanino, PM Tamhankar, ... Human mutation 31 (1), E1071-E1080, 2010 | 96 | 2010 |
| Congenital hypoplastic anemia, diabetes, and severe renal tubular dysfunction associated with a mitochondrial DNA deletion A Majander, A Suomalainen, K Vettenranta, H Sariola, M Perkio, ... Pediatric research 30 (4), 327-330, 1991 | 96 | 1991 |
| Human herpesvirus‐6 and‐7 in pediatric stem cell transplantation H Savolainen, I Lautenschlager, H Piiparinen, U Saarinen‐Pihkala, ... Pediatric blood & cancer 45 (6), 820-825, 2005 | 90 | 2005 |
| Intermittent versus continuous PEG-asparaginase to reduce asparaginase-associated toxicities: a NOPHO ALL2008 randomized study BK Albertsen, K Grell, J Abrahamsson, B Lund, K Vettenranta, ... Journal of Clinical Oncology 37 (19), 1638-1646, 2019 | 88 | 2019 |
| Complying with the European Clinical Trials directive while surviving the administrative pressure–an alternative approach to toxicity registration in a cancer trial TL Frandsen, M Heyman, J Abrahamsson, K Vettenranta, A Åsberg, ... European journal of cancer 50 (2), 251-259, 2014 | 84 | 2014 |
| CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults—An array CGH study A Usvasalo, S Savola, R Räty, K Vettenranta, A Harila-Saari, P Koistinen, ... Leukemia research 32 (8), 1228-1235, 2008 | 82 | 2008 |
